Analysis of 3p allelic losses in renal cell carcinomas: Comparison with cytogenetic results

Cancer Genetics and Cytogenetics

Volumn 107, Issue 2, 1998, Pages 121-124

  Bernués, Marta ^a   Casadevall, Carme ^a   Miró, Rosa ^a   Caballín, María Rosa ^a   Gelabert, Antoni ^b   Ejarque, María José ^c   Chéchile, Gilberto ^c   Egozcue, José ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 3P; CHROMOSOME LOSS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; NEPHRECTOMY; NEPHROURETERECTOMY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEINS C-RAF;

EID: 0032400884     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00090-9     Document Type: Article

References (26)

1. Kovacs G. Papillary renal cell carcinoma. a morphologic and cytogenetic study of 11 cases Am J Pathol. 134:1989;27-34.
2. Kovacs G., Wilkens L., Papp T., De Riese W. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst. 81:1989;527-530.
3. Kovacs G., Fuzesi L., Emanuel A., Kung H.F. Cytogenetics of papillary renal cell tumors. Genes Chromosom Cancer. 3:1991;249-255.
4. Bentz M., Bergerheim U.S.R., Li C., Joos S., Werner C.A., Baudis M., Gnarra J., Merino M.J., Zbar B., Linehan W.M., Lichter P. Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. Cytogenet Cell Genet. 75:1996;17-21.
5. Thrash-Bingham C.A., Greenberg R.E., Howard S., Bruzel A., Bremer M., Goll A., Salazar H., Freed J.J., Tartof K.D. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci USA. 92:1995;2854-2858.
6. Thrash-Bingham C.A., Salazar H., Freed J.J., Greenberg R.E., Tartof K.D. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res. 55:1995;6189-6195.
7. Béroud C., Fournet J.C., Jeanpierre C., Droz D., Bouvier R., Froger D., Chrétien Y., Maréchal J.M., Weissebach J., Junien C. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas. Genes Chromosom Cancer. 17:1996;215-224.
8. Presti J.C. Jr., Reuter V.E., Cordón-Cardo C., Mazumdar M., Fair W.R., Jhanwar S.C. Allelic deletions in renal tumors. histopathological correlations Cancer Res. 53:1993;5780-5783.
9. Van der Hout A.H., Van den Berg E., Van der Vlies P., Dijkhuizen T., Störkel S., Oosterhuis J.W., De Jong B., Buys C.H.C.M. Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer. 53:1993;353-357.
10. Gnarra J.R., Tory K., Weng Y., Schimdt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.M., Lubensky I., Duan D.R., Florence C., Pozzatti R., Walther M.M., Bander N.H., Grossman H.B., Brauch H., Pomer S., Brooks J.D., Isaacs W.B., Lerman I., Zbar B., Linehan W.M. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 7:1994;85-90.
11. Herman J.G., Latif F., Weng Y., Lerman M.I., Zbar B., Liu S., Samid D., Duan D.R., Gnarra J.R., Linehan W.M., Baylin S.B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 91:1994;9700-9704.
12. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 327:1987;721-723.
13. Yamakawa K., Morita R., Takahashi E., Hori T., Ishikawa J., Nakamura Y. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res. 51:1991;4707-4711.
14. Van den Berg A., Hulsbeeck M.M.F., De Jong D., Kok K., Veldhuis P.M.J.F., Roche J., Buys C.H.C.M. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosom Cancer. 15:1996;64-72.
15. Van den Berg A., Buys C.H.C.M. Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosom Cancer. 19:1997;59-76.
16. Decker H.J.H., Weidt E.J., Brieger J. The Von Hippel-Lindau tumor suppressor gene. Cancer Genet Cytogenet. 93:1997;74-83.
17. Seizinger B.R., Rouleau G.A., Ozelius L.J., Lane A.H., Farmer G.E., Lamiell J.M., Haines J., Yuen J.W.M., Collins D., Majoor-Krakauer D., Bonner T., Mathew C., Rubenstein A., Halperin J., McConkie-Rosell A., Green S.J., Trofatter J.A., Ponder B.A., Eierman L., Bowmer M.I., Schimke R., Oostra B., Aronin N., Smith D.I., Drabkin H., Waziri M.H., Hobbs W.J., Martuza R.L., Conneally P.M., Hsia Y.E., Gusella J.F. Von Hippel-Lindau disease maps to the region of the chromosome 3 associated with renal cell carcinoma. Nature. 332:1988;268-269.
18. Kovacs G., Emanuel A., Neumann H.P.H., Kung H.F. Cytogenetics of renal cell carcinomas associated with Von Hippel-Lindau disease. Genes Chromosom Cancer. 3:1991;256-262.
19. Shuin T., Kondo K., Torigoe S., Kishida T., Kubota Y., Hosaka M., Nagashima Y., Kitamura H., Latif F., Zbar B., Lerman M.I., Yao M. Frequent somatic mutations and loss of heterozygosity of the Von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54:1994;2852-2855.
20. Schmidt L., Duh R.M., Chen F., Kishida T., Glenn G., Choyke P., Scherer S.W., Zhuang Z., Lubensky I., Dean M., Allikmets R., Chidambaram A., Bergerheim U.R., Feltis J.T., Casadevall C., Zamarrón A., Bernués M., Richard S., Lips C.J.M., Walther M.M., Tsui L.C., Geil L., Orcutt M.L., Stackhouse T., Lipan J., Slife L., Brauch H., Decker J., Niehans G., Hughson M.D., Moch H., Störkel S., Lerman M.I., Linehan W.M., Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet. 16:1997;68-73.
21. Zhao W.P., Gnarra J.R., Liu S., Knutsen T., Linehan W.M., Whang-Peng J. Renal cell carcinoma. cytogenetic analysis of tumors and cell lines Cancer Genet Cytogenet. 82:1995;128-139.
22. Bernués M., Casadevall C., Miró R., Caballín M.R., Villavicencio H., Salvador J., Zamarrón A., Egozcue J. Cytogenetic characterization of a familial papillary renal cell carcinoma. Cancer Genet Cytogenet. 84:1995;123-127.
23. Li F.P., Decker H.J.H., Zbar B., Stanton V.P. Jr., Kovacs G., Seizinger B.R., Aburatani H., Sandberg A.A., Berg S., Hosoe S., Brown R.S. Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann Int Med. 118:1993;106-111.
24. Van den Berg A., Hulsbeek M.M.F., De Jong D., Kok K., Veldhuis M.J.F., Roche J., Buys C.H.C.M. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosom Cancer. 15:1996;64-72.
25. Hughson M.D., Meloni A.M., Dunn T., Silva F.G., Sandberg A.A. Analysis of 3p allelic loss of papillary and nonpapillary renal cell carcinomas. a correlation of PCR and Southern blotting techniques Mod Pathol. 8:1991;77A.
26. Hughson M.D., Meloni A., Dougherty S., Silva F.G., Sandberg A.A. Analysis of 3p allelic loss in papillary and nonpapillary renal cell carcinomas. correlation with tumor karyotype Cancer Genet Cytogenet. 87:1996;133-139.